Scale -


  • PBT is 27.24 Rs Cr; Continuous Growth over 3 years; Annual Decline is -15 %
  • Quarterly Revenue is 222 Rs Cr; Continuous Growth over 3 Quarters
  • Quarterly Profit is 20.36 Rs Cr; Continuous Growth over 3 Quarters
  • Revenue is 781 Rs Cr; in Top Quartile
  • Ebitda is 84.79 Rs Cr; in Top Quartile; Annual Decline is -16 %

Profitability -


  • Quarterly Profit margin is 9 %; Continuous Growth over 3 Quarters
  • PBDIT Margin is 10.86 %; in Top Quartile
  • PAT Margin is 5.7 %; in Top Quartile

Return -


  • ROA is 5.53 %; in Top Quartile
  • ROCE is 10.82 %; Annual Decline is -24 %
  • ROE is 7.81 %; Annual Decline is -21 %
  • Asset Turnover is 100 %; Continuous Decline over 3 years

Efficiency -


  • Current Ratio is 2.89; Continuous Growth over 3 years
  • Operating cash flow is 34.24 Rs Cr; 5 Year CAGR is 27 %; Annual Decline is -69 %

Solvancy -


  • Debt/Equity is 0; in Bottom Quartile
  • Long term Debt is 0 Rs Cr; in Bottom Quartile
  • Total Debt is 0 Rs Cr; in Bottom Quartile
  • Contingent Liabilities is 54.63 Rs Cr; in Top Quartile

Quality -


  • Change in Inventories/Total Expenses is -2 %; Annual Decline is -450 %; Continuous Decline over 3 years; in Bottom Quartile
  • Exceptional Items/PBT is -9 %; in Bottom Quartile; Annual Growth is 33 %
  • Operating cashflow/ebitda is 40 %; 5 Year CAGR is 21 %; Annual Decline is -63 %; Continuous Decline over 3 years
  • Operating cashflow/PAT is 77 %; 5 Year CAGR is 26 %; Annual Decline is -64 %; Continuous Decline over 3 years
  • Other Expenses/Total Expenses is 24 %; Continuous Growth over 3 years
  • Current Tax/PAT is 37 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
ChemPharma R&D Summit 2026 to tackle R&D pipeline resiliency and cross-border regulatory challenges
Vipul Organics appoints Tushar Jagtap as sales president for India